Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re‐Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz‐Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cellular and molecular medicine 2011-05, Vol.15 (5), p.1225-1225
Hauptverfasser:	Paz‐Ares, Luis, Moecks, Joachim, Klughammer, Barbara
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - genetics Chemotherapy Humans Letter to the Editor Lung Neoplasms - drug therapy Lung Neoplasms - genetics Mutation - genetics Patients Protein Kinase Inhibitors - therapeutic use Receptor, Epidermal Growth Factor - genetics
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!